Why Amylyx Pharmaceuticals Stock Skyrocketed Today
GLP-1 drugs aren't just for weight loss.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
One page, thousands of outlets. See who else covered it.
GLP-1 drugs aren't just for weight loss.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
The EUR/JPY registers two consecutive days of gains, but on Tuesday, buyers failed to gain traction as they faced a confluence of key resistance levels near the 184.70 area.
Cespira revenue surged 125% while net losses narrowed significantly.
Backlog doubled to $2 billion as AI infrastructure demand surges.
Vlad Tenev says tokenized stocks could bring real-time settlement and 24/7 trading, but U.S. rules remain a hurdle.
Revenue grew to $3.1 million despite academic funding headwinds.
Revenue doubled as Vivistim unit sales and active territories expanded.